array:5 [
  "content-type" => array:1 [
    0 => "text/html; charset=UTF-8"
  ]
  "cache-control" => array:1 [
    0 => "no-cache, private"
  ]
  "date" => array:1 [
    0 => "Mon, 20 Jan 2025 11:15:06 GMT"
  ]
  "set-cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6ImE0bDRKRHZEOVpBUnNrSWZrTVExK0E9PSIsInZhbHVlIjoiZktPeHlwMUVUMVpjNC9TcnVMdG9KVFdVVTh2bS9lSEtSR3lNU2ZLdzZQUWdEVXZjcXliVnR1cml1b3dCWkJONUVuSzlLN28vZTViQnpGZlpweXBwWjJLSy8xQTNVU2ZEcm1HK3J3Mk5jZG5lMWlBWWFXQnFKZ0Y1R0JKc3JNb1EiLCJtYWMiOiJjNzkwMWIxYzFkNGM4ZjFlZWU1ZGUwODg4ZTA5ZjgzMDZjMDdiZmI2NjZiMzE3ZTEyZGQwNjYwYTZkMDlmOWVhIiwidGFnIjoiIn0%3D; expires=Tue, 20 Jan 2026 11:15:06 GMT; Max-Age=31536000; path=/; secure; samesite=lax"
    1 => "republica_session=eyJpdiI6IlYrTFk0NWRJc0lSb2M1TjJ2SU1hc2c9PSIsInZhbHVlIjoiN2JpbUxrak4wbk8wWlk3Vy9XSXdyVDJXeGg5Y0o0TjN6YXZwQ3ZUZjBPSHIvMkZLVVlPWktobW00bldrU0Y4eE1uUjhjYzZJMUduTmpVWGJBNkkzczU5NHdTcTZrdTR3TFMrcHNSTmVDRDE3ampQRGFBZlpGT2lwU0lRNDdvVnQiLCJtYWMiOiJiZmQzMTE3NDMwZTlkYmUyNjkxZDU3NDRiOTNlMDVlY2ZkN2I4NjFiZmMxZGFiODExYWE1MTQzMzE2YWJkMGEwIiwidGFnIjoiIn0%3D; expires=Tue, 20 Jan 2026 11:15:06 GMT; Max-Age=31536000; path=/; secure; httponly; samesite=lax"
  ]
  "Set-Cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6ImE0bDRKRHZEOVpBUnNrSWZrTVExK0E9PSIsInZhbHVlIjoiZktPeHlwMUVUMVpjNC9TcnVMdG9KVFdVVTh2bS9lSEtSR3lNU2ZLdzZQUWdEVXZjcXliVnR1cml1b3dCWkJONUVuSzlLN28vZTViQnpGZlpweXBwWjJLSy8xQTNVU2ZEcm1HK3J3Mk5jZG5lMWlBWWFXQnFKZ0Y1R0JKc3JNb1EiLCJtYWMiOiJjNzkwMWIxYzFkNGM4ZjFlZWU1ZGUwODg4ZTA5ZjgzMDZjMDdiZmI2NjZiMzE3ZTEyZGQwNjYwYTZkMDlmOWVhIiwidGFnIjoiIn0%3D; expires=Tue, 20-Jan-2026 11:15:06 GMT; path=/; secure"
    1 => "republica_session=eyJpdiI6IlYrTFk0NWRJc0lSb2M1TjJ2SU1hc2c9PSIsInZhbHVlIjoiN2JpbUxrak4wbk8wWlk3Vy9XSXdyVDJXeGg5Y0o0TjN6YXZwQ3ZUZjBPSHIvMkZLVVlPWktobW00bldrU0Y4eE1uUjhjYzZJMUduTmpVWGJBNkkzczU5NHdTcTZrdTR3TFMrcHNSTmVDRDE3ampQRGFBZlpGT2lwU0lRNDdvVnQiLCJtYWMiOiJiZmQzMTE3NDMwZTlkYmUyNjkxZDU3NDRiOTNlMDVlY2ZkN2I4NjFiZmMxZGFiODExYWE1MTQzMzE2YWJkMGEwIiwidGFnIjoiIn0%3D; expires=Tue, 20-Jan-2026 11:15:06 GMT; path=/; secure; httponly"
  ]
]
New cancer vaccine shows early promise for patients with HER2-positive cancers

New cancer vaccine shows early promise for patients with HER2-positive cancers

Create an account, or log in
